Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
Clinical trial NCT02216214 · COMPLETED
Trial details
- NCT number
- NCT02216214
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-07
- Primary completion
- 2017-11-29
- Enrollment
- 888
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.